Philip Tsai - 29 Jul 2025 Form 4 Insider Report for Immunome Inc. (IMNM)

Reporting relationship: Chief Technical Officer
Issuer ticker: IMNM
Reported as of: 29 Jul 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 31 Jul 2025, 19:00:44 UTC
Prior SEC filing: 25 Mar 2025
Next SEC filing: 22 Dec 2025
Source filing: View source filing
Reporting owner signature: /s/ Sandra Stoneman, Attorney-in-Fact

Key filing fact

Philip Tsai filed Form 4 for Immunome Inc. (IMNM) on 31 Jul 2025.

Key facts

This page summarizes Philip Tsai's Form 4 filing for Immunome Inc. (IMNM).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 31 Jul 2025, 19:00.

Change

Previous filing in this sequence was filed on 25 Mar 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002026600 Primary reporting owner

Tsai Philip

Relationship: Chief Technical Officer
Address: C/O IMMUNOME, INC., 18702 N. CREEK PARKWAY, SUITE 100, BOTHELL
Signature: /s/ Sandra Stoneman, Attorney-in-Fact
Signature date: 31 Jul 2025

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

IMNM transaction Derivative

Employee Stock Option (right to buy)

Award

Transaction value: $0
Shares: +190,000
Change %
Price: $0.000000
Shares after: 190,000
Date: 29 Jul 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 190,000
Exercise price: $10.60
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

25% of the shares subject to the options vest on July 29, 2026, and one-thirty-sixth (1/36th) of the remaining shares subject to the options shall vest every month thereafter.